Xbiotech Inc (XBIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 109,528 | 115,459 | 125,551 | 147,367 | 152,938 |
| Receivables | 291 | 302 | 360 | 525 | 638 |
| TOTAL | $111,159 | $117,049 | $126,953 | $148,951 | $154,889 |
| Non-Current Assets | |||||
| PPE Net | 22,492 | 22,787 | 23,129 | 23,473 | 23,793 |
| TOTAL | $22,492 | $22,787 | $23,129 | $23,473 | $23,793 |
| Total Assets | $133,651 | $139,836 | $150,082 | $172,424 | $178,682 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,105 | 857 | 1,535 | 1,043 | 1,431 |
| Accrued Expenses | 2,248 | 2,035 | 6,318 | 2,422 | 2,410 |
| TOTAL | $3,353 | $2,999 | $7,929 | $3,565 | $3,857 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,832 | 1,815 | 1,798 | 1,779 | 1,761 |
| TOTAL | $1,837 | $1,820 | $1,803 | $1,779 | $1,761 |
| Total Liabilities | $5,190 | $4,819 | $9,732 | $5,344 | $5,618 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,488 | 30,488 | 30,488 | 30,488 | 30,488 |
| Common Shares | 277,071 | 276,899 | 276,727 | 276,565 | 276,541 |
| Retained earnings | -148,610 | -141,882 | -136,377 | -109,485 | -103,477 |
| TOTAL | $128,461 | $135,017 | $140,350 | $167,080 | $173,064 |
| Total Liabilities And Equity | $133,651 | $139,836 | $150,082 | $172,424 | $178,682 |